Table 7 highlights how anthocyanidins reduce liver fibrosis by inhibiting key fibrotic processes such as HSC activation, inflammation, oxidative stress, and collagen deposition, while enhancing antioxidant defenses, promoting apoptosis, and modulating signaling pathways such as Nrf2 and TGF-β/Smad, contributing to improved liver function and reduced fibrosis. Here, TGFB1 is linked to Hepatic fibrosis.